GISMO THERAPEUTICS
Gismo Therapeutics is a biotechnology startup that develops and offers small-molecule therapeutics for the treatment of Alzheimer’s and Parkinson’s diseases. It was founded in 2013 and is based in Lexington, Kentucky, United States.
GISMO THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2013-01-01
Address:
Lexington, Kentucky, United States
Country:
United States
Website Url:
http://www.gismotherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
3472517342
Email Addresses:
[email protected]
Total Funding:
235 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API WordPress Wordpress Plugins Nginx Euro PHP PHP 7
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Palisade Therapeutics
Palisade Therapeutics develops therapeutics-based products for the treatment of neurological diseases.
Saccharo
Saccharo is a biotech start-up in the immuno-oncology space that develops products for the treatment of cancer and other novel diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.gismotherapeutics.com
- Host name: 54.244.178.68.host.secureserver.net
- IP address: 68.178.244.54
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Gismo Therapeutics"
Overview – Gismo Therapeutics, Inc.
TEAM - Gismo Therapeutics
Choi previously served as chairman of the U.S. National Committee to the International Brain Research Organization, vice-president of the American Neurological Association, and founding …See details»
Gismo Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 3472517342 Gismo Therapeutics is a biotechnology startup that develops and offers small-molecule therapeutics for the treatment of …See details»
Gismo Therapeutics Inc. - LinkedIn
GISMO THERAPEUTICS INC. is a privately funded biotech start-up company incorporated in 2011. The company is developing novel oral therapeutics for Alzheimer’s and Parkinson's …See details»
Gismo Therapeutics Inc. Company Profile - Dun & Bradstreet
Address: 145 Graham Ave A253 Astecc Build Lexington, KY, 40506-0001 United StatesSee details»
Gismo Therapeutics | Seed - National Institutes of Health
Gismo Therapeutics Inc. is a biotech start-up company targeting fundamental biochemical processes that are at the root cause of Alzheimer’s and Parkinson’s Disease pathogenesis.See details»
GISMO THERAPEUTICS, INC. - VentureRadar
Gismo Therapeutics Inc. is a preclinical-stage biopharmaceutical company targeting fundamental biochemical processes that are at the root cause of... ... Find out ...See details»
Gismo Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Gismo Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 literature, Disease Domain:Nervous System Diseases, Endocrinology ...See details»
Gismo Therapeutics Inc. Information - RocketReach
GISMO THERAPEUTICS INC. is a privately funded biotech start-up company incorporated in 2011. The company is developing novel oral therapeutics for Alzheimer’s and Parkinson's …See details»
Gismo Therapeutics - Craft
Gismo Therapeutics is a biotech company that develops oral therapeutics for Alzheimer’s and Parkinson's disease. Its technology platform enables the production of disease-modifying …See details»
Gismo Therapeutics - Overview, News & Similar companies
Gismo Therapeutics contact info: Phone number: (347) 233-2037 Website: www.gismotherapeutics.com What does Gismo Therapeutics do? Gismo Therapeutics Inc. is …See details»
Gismo Therapeutics - Products, Competitors, Financials, Employees ...
Dec 3, 2014 Gismo Therapeutics Inc. Receives a Michael J. Fox Foundation for Parkinson’s Research Grant. Dec 3, 2014. Caprion gets Fox Foundation grant for Parkinson's biomarkers …See details»
GISMO THERAPEUTICS, INC. - VentureRadar
Website: http://www.gismotherapeutics.com/ Develops preclinical-stage biopharmaceuticals targeting biochemical processes causing neurodegenerative diseases, focusing ...See details»
Gismo Therapeutics Company Profile | Management and
Company Name. Gismo Therapeutics. Main Industry. Research & Development, Business Services. Website. www.gismotherapeutics.comSee details»
Investors – Gismo Therapeutics, Inc.
Email: [email protected]. News and Events. Gismo Therapeutics Inc. Receives Funding to Develop an Innovative Therapeutic for Alzheimer’s Disease August 25, 2023; …See details»
Gismo Therapeutics Inc. Receives Funding to Develop an …
For more information about Gismo Therapeutics Inc., visit the company’s website, www.gismotherapeutics.com. Contact: Dr. Paul Gregor Tel: (347) 233-2037 e-mail: …See details»
Gismo Therapeutics, Inc. (Gismo Therapeutics, Inc.) - 药物管线_专 …
了解Gismo Therapeutics, Inc. (Gismo Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的2篇文献，疾病领域:神经系统疾病，内分泌与代谢疾病，技术平台:小分子化药，其 …See details»
New study results reinforce TAGRISSO® (osimertinib) as the …
3 days ago New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca’s TAGRISSO ® (osimertinib), as …See details»
New study results reinforce Tagrisso as the backbone therapy for …
2 days ago New study results presented at the European Lung Cancer Congress (ELCC) 2025, 26 to 29 March, demonstrate the role of AstraZeneca’s Tagrisso (osimertinib), as monotherapy …See details»
Biotech Startup Gismo Therapeutics Receives Funding to Develop …
For more information about Gismo Therapeutics Inc., visit the company’s website, www.gismotherapeutics.com. Contact: Dr. Paul Gregor Tel: (347) 233-2037 e-mail: …See details»